BioNexus Gene Lab Corp (BGLC): Total Assets
$9.25M
As of 2025-12-31
$8.73M
As of 2026-06-30
+1.9%
3-year compound annual growth
-1.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.25M | -11.3% | 2026-04-14, Balance as of period end |
| 2024-12-31 | $10.43M | -8.5% | 2026-04-14, Balance as of period end |
| 2023-12-31 | $11.40M | +30.4% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $8.74M | -8.7% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $9.57M | -5.3% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $10.12M | +721.6% | 2022-04-06, Balance as of period end |
| 2019-12-31 | $1.23M | -25.5% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $1.65M | n/a | 2020-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $9.25M | -11.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
| YD Bio Ltd (YDES) | 2025-12-31 | $13.78M | +100.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗